Regulatory approvals for new treatments are also playing a critical role in driving this expansion. Key contributors to market growth include notable advancements in immunotherapy techniques, such as CAR-T cell therapies and monoclonal antibodies, which have markedly improved treatment outcomes for patients with various forms of blood cancer. This is particularly important given